Page last updated: 2024-09-05

sb 203580 and tolfenamic acid

sb 203580 has been researched along with tolfenamic acid in 1 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(tolfenamic acid)
Trials
(tolfenamic acid)
Recent Studies (post-2010) (tolfenamic acid)
3,48941,13729447132

Protein Interaction Comparison

ProteinTaxonomysb 203580 (IC50)tolfenamic acid (IC50)
phospholipase A2 precursorHomo sapiens (human)7.74
cysteine protease ATG4B isoform aHomo sapiens (human)8.17
Cytochrome c oxidase subunit 2Homo sapiens (human)1.29
Prostaglandin G/H synthase 2Homo sapiens (human)0.88

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hwang, HS; Jittreetat, T; Kim, CH; Kim, YS; Lee, BS; Sannikorn, P; Shin, YS1

Other Studies

1 other study(ies) available for sb 203580 and tolfenamic acid

ArticleYear
Tolfenamic Acid Inhibits the Proliferation, Migration, and Invasion of Nasopharyngeal Carcinoma: Involvement of p38-Mediated Down-Regulation of Slug.
    Yonsei medical journal, 2016, Volume: 57, Issue:3

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carcinoma; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Down-Regulation; Gastropoda; Gene Expression Regulation, Neoplastic; Hepatocyte Growth Factor; Humans; Imidazoles; MAP Kinase Signaling System; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; ortho-Aminobenzoates; Phosphorylation; Pyridines

2016